Expert consensus decision pathway developed for patients currently taking statins and needing additional treatment
Dapagliflozin Cuts CV Risk in Heart Failure With Preserved LVEF
Risk reduced for primary outcome of worsening heart failure or cardiovascular death
Acetazolamide Helps Treat Volume Overload in Heart Failure
Rate of successful decongestion higher with addition of acetazolamide to loop diuretic in patients with acute decompensated heart failure
Device-Measured Physical Activity Tied to Heart Failure Risk
Risk reduced for 150 to 300 min/week of moderate-intensity physical activity and for 75 to 150 min/week vigorous-intensity physical activity